Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection

AIDS

Volumn 14, Issue 3, 2000, Pages 225-233

  Wilson, Jamie D K ^d   Ogg, Graham S ^d   Allen, Rachel L ^d   Davis, Claire ^a   Shaunak, Sunil ^a   Downie, Jean ^b   Dyer, Wayne ^b   Workman, Cassie ^b   Sullivan, John S ^b   McMichael, Andrew J ^d   Rowland Jones, Sarah L ^c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NSW Blood Bank   (Australia)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d NONE

Author keywords

Acute infection; Class I MHC peptide tetrameric complexes; Cytotoxic T lymphocyte; Fluorescent antibody cell sorting

Indexed keywords

ANTIRETROVIRUS AGENT; CD8 ANTIGEN; EPITOPE; HLA ANTIGEN CLASS 1;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; SEROCONVERSION; STEM CELL; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HUMANS; MALE;

EID: 0001426414     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200002180-00003     Document Type: Article

References (32)

1. 1. Rowland-Jones SL, Tan R, McMichael AJ. The role of cellular immunity in protection against HIV infection. Adv Immunol 1997, 65:277-346.
2. 2. Koup RA., Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994, 68:4650-4655.
3. 3. Pantaleo G, Demarest JF, Schacker T, et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci USA 1997, 94:254-258.
4. 4. Matano T, Shibata R, Siemon C, Connors M, Lane H, Martin M. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J Virol 1998, 72:164-169.
5. 5. Ogg GS, Xin J, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma viral RNA load. Science 1998, 279:2103-2106.
6. 6. Phillips RE, Rowland-Jones SL, Nixon DF, et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991, 354:453-459.
7. 7. Price DA, Goulder PJ, Klenerman P, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997, 94:1890-1895.
8. 8. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997, 3:205-211.
9. 9. Rowland-Jones SL, Sutton J, Ariyoshi K, et al. HIV-specific cytotoxic T cells in HIV-exposed but uninfected Gambian women. Nature Med 1995, 1:59-64.
10. 10. Gotch FM, Nixon DF, Alp N, McMichael AJ, Borysiewicz LK. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int Immunol 1990, 2:707-712.
11. 11. Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocytes (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993, 177:249-256.
12. 12. Moss PAH, Rowland-Jones SL, Frodsham PM, et al. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc Natl Acad Sci USA 1995, 92:5773-5777.
13. 13. Kalams SA, Johnson RP, Trocha AK, et al. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J Exp Med 1994, 179: 1261-1271.
14. 14. Altman J, Moss PAH, Goulder P, et al. Direct visualization and phenotypic analysis of virus-specific T lymphocytes in HIV-infected individuals. Science 1996, 274:94-96.
15. 15. Wilson JDK, Ogg GS, Allen RL, et al. Oligoclonal expansions of CD8(+) T cells in chronic HIV infection are antigen specific. J Exp Med 1998, 188:785-790.
16. 16. Kuroda MJ, Schmitz JE, Barouch DH, et al. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class 1-peptide complex. J Exp Med 1998, 187:1373-1381.
17. 17. Callan MF, Tan L, Annels N, et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998, 187:1395-1402.
18. 18. Murali-Krishna K, Altman JD, Suresh M, et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998, 8:177-187.
19. 19. Pantaleo G, Koenig S, Baseler M, Lane HC, Fauci AS. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+ CD8+DR+CD25-T cell population. J Immunol 1990, 144:1696-1704.
20. 20. Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med 1997, 3:212-217.
21. 21. Brettle RP, McNeil AJ, Burns S, et al. Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS 1996, 10:419-430.
22. 22. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers. Tissue Antigens. 1995, 46:355-367.
23. 23. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ. Rapid effector function in CD8+ memory T cells. J Exp Med 1997, 186:859-865.
24. 24. Korber B, Moore J, Brander C, Walker B, Haynes B, Koup R. HIV Molecular Immunology Database, 1997. Los Alamos: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory.
25. 25. Tsomides TJ, Walker BD, Eisen HN. An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class 1 major histocompatibility complex protein on intact cells but not to the purified class 1 protein. Proc Natl Acad Sci USA 1991, 88:11276-11280.
26. 26. Nixon DF, Townsend ARM, Elvin JG, Rizza CR, Gallwey J, McMichael AJ. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988, 336:484-487.
27. 27. Rowland-Jones S, McMichael A. Cytotoxic T lymphocytes in HIV infection. Semin Virol 1993, 4:83-94.
28. 28. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to 'benign monoclonal gammapathy'. J Exp Med 1994, 179:609-618 (erratum: J Exp Med 1994, 179:1077).
29. 29. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997, 337:1267-1274.
30. 30. Pantaleo G, Demarest JF, Soudeyns H, et al. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 1994, 370:463-467.
31. 31. Yasutomi Y, Reimann KA, Lord CI, Miller MD, Letvin NL. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J Virol 1993, 67:1707-1711.
32. 32. Koup RA, Pikora CA, Luzuriaga K, et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J Exp Med 1991, 174:1593-1600.